Esophageal Adenocarcinoma Clinical Trials in Chicago, Illinois

5 studies are recruiting for esophageal adenocarcinoma in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

   The purpose of this study is to learn the best approach to treating patients with known or suspected Barrett's esophagus by comparing endoscopic surveillance to endoscopic eradication therapy. To diagnose and manage Barrett's esophagus and low-grade dysplasia, doctors commonly use procedures called…

   Stage

   Not phased

   Ages

   18 to 89

   Site

   Northwestern Memorial Hospital, Chicago, Illinois

   Locations

   30 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT05753748 on ClinicalTrials.gov

2. Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

   This study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to people with gastroesophageal cancer that is locally advanced (spread to nearby tissues) or has spread to other parts of the body. To join the study, participants must…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Illinois Cancer Specialists, Chicago, Illinois

   Locations

   74 in total

   Run by

   Pfizer

   See if you can join NCT07392892 on ClinicalTrials.gov

3. A Study of Sigvotatug Vedotin in Advanced Solid Tumors

   This trial will look at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors. It will study sigvotatug vedotin to find out what its side effects are. A side effect is anything the drug …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UChicago Medicine - River East, Chicago, Illinois

   Locations

   158 in total

   Run by

   Seagen, a wholly owned subsidiary of Pfizer

   See if you can join NCT04389632 on ClinicalTrials.gov

4. Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

   The purpose of this research study is to learn about the best approach to sample patients with known or suspected Barrett's esophagus (BE) by comparing the standard Seattle biopsy protocol to sampling using wide area transepithelial sampling (WATS3D). Barrett's esophagus is a common condition that …

   Stage

   Not phased

   Ages

   18 to 89

   Site

   Northwestern University, Chicago, Illinois

   Locations

   14 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT05530343 on ClinicalTrials.gov

5. Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

   This clinical trial evaluates the use of cytosponge, a minimally invasive collection device, for the detection of Barrett's esophagus (BE) in patients undergoing endoscopy. Non-endoscopic swallowable encapsulate sponge cell collection devices combined with markers for BE/esophageal adenocarcinoma (…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   Northwestern University, Chicago, Illinois

   Locations

   5 in total

   Run by

   Mayo Clinic

   See if you can join NCT06071845 on ClinicalTrials.gov